对慢性肾衰血液透析的高磷血症患者的疗效和安全性的随机、双盲、阳性药物平行对照多中心的临床试验方案
[Translation] A randomized, double-blind, positive drug parallel controlled multicenter clinical trial protocol for the efficacy and safety of hyperphosphatemia in patients with chronic renal failure undergoing hemodialysis
验证碳酸司维拉姆片治疗中国慢性肾脏病血液透析高磷血症患者的疗效及安全性
[Translation] To verify the efficacy and safety of sevelamer carbonate tablets in the treatment of hyperphosphatemia in Chinese patients with chronic kidney disease undergoing hemodialysis
100 Clinical Results associated with Nanjing Lifenergy R&D Co., Ltd.
0 Patents (Medical) associated with Nanjing Lifenergy R&D Co., Ltd.
100 Deals associated with Nanjing Lifenergy R&D Co., Ltd.
100 Translational Medicine associated with Nanjing Lifenergy R&D Co., Ltd.